Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-01-05 @ 5:59 PM
Study NCT ID:
NCT05175950
Status:
UNKNOWN
Last Update Posted:
2023-02-14
First Post:
2022-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)
Sponsor:
Korea University Guro Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-03
First Submit QC Date:
None
Study First Post Date:
2022-01-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-12
Last Update Post Date:
2023-02-14
Last Update Post Date Type:
ACTUAL